whytestocks
6 years ago
News: $HEB Hemispherx Biopharma Stockholders Approve Reverse Stock Split
OCALA, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases, today announced that its stockholders voted in...
Read the whole news https://marketwirenews.com/news-releases/hemispherx-biopharma-stockholders-approve-reverse-stock-split-8277778.html
whytestocks
6 years ago
News: $HEB Hemispherx Links Stanford's ME/CFS Diagnostic to a Potential Path Forward for Ampligen Commercialization
OCALA, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases — and whose product portfolio includes Amp...
In case you are interested https://marketwirenews.com/news-releases/hemispherx-links-stanford-s-me-cfs-diagnostic-to-a-potential-path-forward-for-ampligen-commercialization-8123236.html